Health ❯Infectious Diseases

Respiratory Syncytial Virus

Statistics Monoclonal Antibody Drugs Severe Illness Chikungunya

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

The biotech firm beats Wall Street estimates, expands cost-reduction targets, and delays its COVID-flu combo vaccine approval to 2026.

ACIP Reconvenes to Vote on Key Vaccine Updates After Two-Month Delay

Grippewelle in Deutschland nimmt Fahrt auf: Fälle und Krankenhauseinweisungen steigen